646055-79-0

Basic information

• Product Name: 1-Azabicyclo[2.2.1]heptane-2-carboxylicacid,ethylester(9CI)
• Synonyms: 1-Azabicyclo[2.2.1]heptane-2-carboxylicacid,ethylester(9CI);ethyl 1-aza-bicyclo[2.2.1]heptane-2-carboxylate
• CAS NO: 646055-79-0
• Molecular Formula: C9H15NO2
• Molecular Weight: 169.22
• Product Categories: PYRROLE;GLYCINESCAFFOLD
• Mol File: 646055-79-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Azabicyclo[2.2.1]heptane-2-carboxylicacid,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Azabicyclo[2.2.1]heptane-2-carboxylicacid,ethylester(9CI)(646055-79-0)
• EPA Substance Registry System: 1-Azabicyclo[2.2.1]heptane-2-carboxylicacid,ethylester(9CI)(646055-79-0)

Safety Data

• Hazardous Substances Data: 646055-79-0(Hazardous Substances Data)

Usage

Explanation

The compound consists of 9 carbon atoms, 15 hydrogen atoms, 1 nitrogen atom, and 2 oxygen atoms.

Explanation

The compound is derived from 1-azabicyclo[2.2.1]heptane-2-carboxylic acid by replacing the hydroxyl group (-OH) with an ethoxy group (-OCH3).

Explanation

Due to its unique structure and properties, this compound is commonly used as an intermediate in the synthesis of various drugs and pharmaceuticals.

Explanation

The compound serves as a reference standard in analytical chemistry and research, helping to calibrate instruments and validate experimental methods.

Explanation

The chemical properties and structure of 1-azabicyclo[2.2.1]heptane-2-carboxylic acid, ethyl ester (9CI) make it suitable for a wide range of applications, particularly in the fields of drug development and research.

Structure

Ester form of 1-azabicyclo[2.2.1]heptane-2-carboxylic acid

Application in pharmaceutical industry

Building block for drug synthesis

Use as a reference standard

Analytical chemistry and research

Suitability for various applications

Drug development and research

Upstream product

• 64-17-5 ethanol 
• 646055-78-9 methyl 2-amino-3-(tetrahydrofuran-3-yl)-propionate 

Downstream Products

• 646055-82-5 1-azaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidine] 
• 646055-81-4 1-azaspiro[bicyclo[2.2.1]heptane-2,3'-pyrrolidin]-2'-one 
• 646055-80-3 ethyl 2-(2-nitroethyl)-1-aza-bicyclo[2.2.1]heptane-2-carboxylate 

Relevant articles and documents

THE USE OF N-ARYL DIAZASPIRACYCLIC COMPOUNDS IN THE TREATMENT OF ADDICTION

Compounds, compositions and methods for treating drug addiction, nicotine addiction, and/or obesity are disclosed. The compounds are N-aryl diazaspirocyclic compounds, bridged analogs of N-heteraryl diazaspirocyclic compounds, or prodrugs or metabolites of these compounds. The aryl group can be a five- or six-membered heterocyclic ring (heteroaryl). The compounds are effective at inhibiting dopamine production and/or secretion, and accordingly are effective at inhibiting the physiological "reward" process that is associated with ingestion of nicotine and/or illicit drugs. The compounds and compositions can be administered in effective amounts to inhibit dopamine release, wihout resulting in appreciable adverse side effects (e.g., side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastro-intestinal tract, and significant effects upon skeletal muscle).